Paramagnetic rim white matter (WM) lesions (PRL) are thought to be a main driver of non-relapsing multiple sclerosis (MS) progression. It is unknown whether cerebrospinal fluid (CSF)-soluble factors diffusing from the ventricles contribute to PRL formation.
Objective:
To investigate the distribution of PRL and non-rim brain WM lesions as a function of distance from ventricular CSF, their relationship with cortical lesions, the contribution of lesion phenotype, and localization to neurological disability.
Methods:
Lesion count and volume of PRL, non-rim WM, leukocortical lesion (LCL), and subpial/intracortical lesions were obtained at 7-T. The brain WM was divided into 1-mm-thick concentric rings radiating from the ventricles to extract PRL and non-rim WM lesion volume from each ring.
Results:
In total, 61 MS patients with ⩾1 PRL were included in the study. Both PRL and non-rim WM lesion volumes were the highest in the periventricular WM and declined with increasing distance from ventricles. A CSF distance-independent association was found between non-rim WM lesions, PRL, and LCL, but not subpial/intracortical lesions. Periventricular non-rim WM lesion volume was the strongest predictor of neurological disability.
Conclusions:
Non-rim and PRL share a gradient of distribution from the ventricles toward the cortex, suggesting that CSF proximity equally impacts the prevalence of both lesion phenotypes.
Dal-BiancoAGrabnerGKronnerwetterC, et al. Slow expansion of multiple sclerosis iron rim lesions: Pathology and 7 T magnetic resonance imaging. Acta Neuropathol2017; 133(1): 25–42.
2.
TreabaCAContiAKlawiterEC, et al. Cortical and phase rim lesions on 7 T MRI as markers of multiple sclerosis disease progression. Brain Commun2021; 3(3): fcab134.
3.
RansohoffRM. Multiple sclerosis: Role of meningeal lymphoid aggregates in progression independent of relapse activity. Trends Immunol2023; 44(4): 266–275.
4.
MaggiPSatiPNairG, et al. Paramagnetic rim lesions are specific to multiple sclerosis: An international multicenter 3T MRI study. Ann Neurol2020; 88(5): 1034–1042.
5.
AbsintaMSatiPSchindlerM, et al. Persistent 7-tesla phase rim predicts poor outcome in new multiple sclerosis patient lesions. J Clin Invest2016; 126(7): 2597–2609.
6.
PoirionEToniettoMLejeuneFX, et al. Structural and clinical correlates of a periventricular gradient of neuroinflammation in multiple sclerosis. Neurology2021; 96(14): e1865–e1875.
7.
ToniettoMPoirionELazzarottoA, et al. Periventricular remyelination failure in multiple sclerosis: A substrate for neurodegeneration. Brain2023; 146(1): 182–194.
8.
LiuZPardiniMYaldizliÖ, et al. Magnetization transfer ratio measures in normal-appearing white matter show periventricular gradient abnormalities in multiple sclerosis. Brain2015; 138(Pt 5): 1239–1246.
9.
BrownJWPardiniMBrownleeWJ, et al. An abnormal periventricular magnetization transfer ratio gradient occurs early in multiple sclerosis. Brain2017; 140(2): 387–398.
10.
KlistornerSBarnettMHGrahamSL, et al. The expansion and severity of chronic MS lesions follows a periventricular gradient. Mult Scler2022; 28(10): 1504–1514.
11.
CalviAClarkeMAPradosF, et al. Relationship between paramagnetic rim lesions and slowly expanding lesions in multiple sclerosis. Mult Scler2023; 29(3): 352–362.
12.
Dal-BiancoAGrabnerGKronnerwetterC, et al. Long-term evolution of multiple sclerosis iron rim lesions in 7 T MRI. Brain2021; 144(3): 833–847.
13.
FilippiMPreziosaPBanwellBL, et al. Assessment of lesions on magnetic resonance imaging in multiple sclerosis: Practical guidelines. Brain2019; 142(7): 1858–1875.
14.
VellingaMMGeurtsJJRostrupE, et al. Clinical correlations of brain lesion distribution in multiple sclerosis. J Magn Reson Imaging2009; 29(4): 768–773.
15.
KurtzkeJF. Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS). Neurology1983; 33(11): 1444–1452.
16.
TreabaCAGranbergTESormaniMP, et al. Longitudinal characterization of cortical lesion development and evolution in multiple sclerosis with 7.0-T MRI. Radiology2019; 291(3): 740–749.
17.
PetersonJWBöLMörkS, et al. Transected neurites, apoptotic neurons, and reduced inflammation in cortical multiple sclerosis lesions: Cortical Lesions in MS. Ann Neurol2001; 50(3): 389–400.
18.
BøLVedelerCANylandHI, et al. Subpial demyelination in the cerebral cortex of multiple sclerosis patients. J Neuropathol Exp Neurol2003; 62(7): 723–732.
19.
MaineroCBennerTRaddingA, et al. In vivo imaging of cortical pathology in multiple sclerosis using ultra-high field MRI. Neurology2009; 73(12): 941–948.
20.
GreveDNFischlB. Accurate and robust brain image alignment using boundary-based registration. Neuroimage2009; 48(1): 63–72.
21.
MagliozziRHowellOWReevesC, et al. A Gradient of neuronal loss and meningeal inflammation in multiple sclerosis. Ann Neurol2010; 68(4): 477–493.
22.
SuthiphosuwanSSatiPAbsintaM, et al. Paramagnetic rim sign in radiologically isolated syndrome. JAMA Neurol2020; 77(5): 653–655.
23.
ClarkeMAParetoDPessini-FerreiraL, et al. Value of 3T susceptibility-weighted imaging in the diagnosis of multiple sclerosis. AJNR Am J Neuroradiol2020; 41(6): 1001–1008.
24.
MargoniMPreziosaPStorelliL, et al. Paramagnetic rim and core sign lesions in paediatric multiple sclerosis patients. J Neurol Neurosurg Psychiatry2023; 94(10): 873–876.
25.
ZhangSNguyenTDHurtado RúaSM, et al. Quantitative susceptibility mapping of time-dependent susceptibility changes in multiple sclerosis lesions. AJNR Am J Neuroradiol2019; 40(6): 987–993.
26.
AramJFrancisATanasescuR, et al. Granulocyte-macrophage colony-stimulating factor as a therapeutic target in multiple sclerosis. Neurol Ther2019; 8(1): 45–57.
27.
CarrieriPBProviteraVDe RosaT, et al. Profile of cerebrospinal fluid and serum cytokines in patients with relapsing-remitting multiple sclerosis: A correlation with clinical activity. Immunopharmacol Immunotoxicol1998; 20(3): 373–382.
28.
HowellOWReevesCANicholasR, et al. Meningeal inflammation is widespread and linked to cortical pathology in multiple sclerosis. Brain2011; 134(Pt 9): 2755–2771.
29.
MagliozziRHowellOVoraA, et al. Meningeal B-cell follicles in secondary progressive multiple sclerosis associate with early onset of disease and severe cortical pathology. Brain2007; 130(Pt 4): 1089–1104.
30.
BeckESMaranzanoJLucianoNJ, et al. Cortical lesion hotspots and association of subpial lesions with disability in multiple sclerosis. Mult Scler2022; 28(9): 1351–1363.
31.
BøLVedelerCANylandH, et al. Intracortical multiple sclerosis lesions are not associated with increased lymphocyte infiltration. Mult Scler2003; 9(4): 323–331.
32.
Gh PopescuBFLucchinettiCF. Meningeal and cortical grey matter pathology in multiple sclerosis. BMC Neurol2012; 12(1): 11.
33.
KiddDBarkhofFMcConnellR, et al. Cortical lesions in multiple sclerosis. Brain1999; 122(Pt 1): 17–26.
34.
KammaELasisiWLibnerC, et al. Central nervous system macrophages in progressive multiple sclerosis: Relationship to neurodegeneration and therapeutics. J Neuroinflammation2022; 19(1): 45.
35.
BhargavaPHartungHPCalabresiPA. Contribution of B cells to cortical damage in multiple sclerosis. Brain2022; 145(10): 3363–3373.
